• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A host-guest relationship in bone morphogenetic protein receptor-II defines specificity in ligand-receptor recognition.配体-受体识别中骨形态发生蛋白受体-II 的主体-客体关系定义了特异性。
Biochemistry. 2012 Sep 4;51(35):6968-80. doi: 10.1021/bi3003023. Epub 2012 Aug 23.
2
Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.人骨形态发生蛋白II型受体胞外域配体结合特性的表征
J Mol Biol. 2008 Apr 18;378(1):191-203. doi: 10.1016/j.jmb.2008.02.031. Epub 2008 Mar 4.
3
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.沉默的氢键可通过突变被激活,用于骨形态发生蛋白-2(BMP-2)与激活素IIB型受体的高亲和力相互作用。
BMC Struct Biol. 2007 Feb 12;7:6. doi: 10.1186/1472-6807-7-6.
4
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.骨形态发生蛋白-2 I型受体复合物的结构分析揭示了青少年息肉病综合征中受体失活的机制。
J Biol Chem. 2008 Feb 29;283(9):5876-87. doi: 10.1074/jbc.M706029200. Epub 2007 Dec 26.
5
Bone morphogenetic proteins.骨形态发生蛋白
Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890.
6
N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.骨形态发生蛋白受体 2(BMPR2)的 N 连接糖基化增强了配体的结合。
Cell Mol Life Sci. 2014 Aug;71(16):3165-72. doi: 10.1007/s00018-013-1541-8. Epub 2013 Dec 15.
7
The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.骨形态发生蛋白-2(BMP-2)与骨形态发生蛋白受体-IA(BMPR-IA)复合物的晶体结构及BMP-2拮抗剂的产生。
J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S7-14.
8
Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue.骨形态发生蛋白受体在肺动脉高压中的转运失败:挽救的可能性。
Hum Mol Genet. 2008 Oct 15;17(20):3180-90. doi: 10.1093/hmg/ddn214. Epub 2008 Jul 21.
9
Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.人骨形态发生蛋白(BMPs)II型受体:双激酶受体模型向BMPs的扩展
Mol Cell Biol. 1995 Jul;15(7):3479-86. doi: 10.1128/MCB.15.7.3479.
10
Structure of the ternary signaling complex of a TGF-beta superfamily member.转化生长因子-β超家族成员的三元信号复合物结构
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7643-8. doi: 10.1073/pnas.0602558103. Epub 2006 May 3.

引用本文的文献

1
Structural Energy Landscapes and Plasticity of the Microstates of Apo cAMP Receptor Protein.apo-cAMP 受体蛋白的微态构象能及塑性的结构能量景观
Biochemistry. 2020 Feb 4;59(4):460-470. doi: 10.1021/acs.biochem.9b00895. Epub 2020 Jan 10.
2
Differential modulation of energy landscapes of cyclic AMP receptor protein (CRP) as a regulatory mechanism for class II CRP-dependent promoters.环腺苷酸受体蛋白(CRP)能量景观的差异调节作为 II 类 CRP 依赖性启动子的调控机制。
J Biol Chem. 2019 Oct 18;294(42):15544-15556. doi: 10.1074/jbc.RA119.009151. Epub 2019 Sep 6.
3
N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.骨形态发生蛋白受体 2(BMPR2)的 N 连接糖基化增强了配体的结合。
Cell Mol Life Sci. 2014 Aug;71(16):3165-72. doi: 10.1007/s00018-013-1541-8. Epub 2013 Dec 15.
4
Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.遗传性肺动脉高压患者内源性表达的 BMPR2 突变等位基因产物的异常转运。
PLoS One. 2013 Nov 5;8(11):e80319. doi: 10.1371/journal.pone.0080319. eCollection 2013.

本文引用的文献

1
BMPs: from bone to body morphogenetic proteins.BMPs:从骨到全身形态发生蛋白。
Sci Signal. 2010 Feb 2;3(107):mr1. doi: 10.1126/scisignal.3107mr1.
2
Cellular and molecular basis of pulmonary arterial hypertension.肺动脉高压的细胞和分子基础
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S20-S31. doi: 10.1016/j.jacc.2009.04.018.
3
Characterizing the role of ensemble modulation in mutation-induced changes in binding affinity.表征整体调节在突变诱导的结合亲和力变化中的作用。
J Am Chem Soc. 2009 May 20;131(19):6785-93. doi: 10.1021/ja809133u.
4
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.BMPR2 突变携带者的肺动脉高压临床结局
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1377-83. doi: 10.1164/rccm.200712-1807OC. Epub 2008 Mar 20.
5
Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.人骨形态发生蛋白II型受体胞外域配体结合特性的表征
J Mol Biol. 2008 Apr 18;378(1):191-203. doi: 10.1016/j.jmb.2008.02.031. Epub 2008 Mar 4.
6
Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.受体复合物中的化学计量失衡导致肺动脉高压中功能失调的骨形态发生蛋白受体II(BMPR-II)介导的信号传导。
Hum Mol Genet. 2008 Jun 1;17(11):1683-94. doi: 10.1093/hmg/ddn059. Epub 2008 Mar 4.
7
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.骨形态发生蛋白-2 I型受体复合物的结构分析揭示了青少年息肉病综合征中受体失活的机制。
J Biol Chem. 2008 Feb 29;283(9):5876-87. doi: 10.1074/jbc.M706029200. Epub 2007 Dec 26.
8
A fluorescence study of type I and type II receptors of bone morphogenetic proteins with bis-ANS (4, 4'-dianilino-1, 1'-bisnaphthyl-5, 5' disulfonic acid).利用双-ANS(4,4'-二苯胺基-1,1'-联萘-5,5'-二磺酸)对骨形态发生蛋白I型和II型受体进行的荧光研究。
Biochim Biophys Acta. 2007 Apr;1774(4):493-501. doi: 10.1016/j.bbapap.2007.02.003. Epub 2007 Feb 14.
9
Functional residues serve a dominant role in mediating the cooperativity of the protein ensemble.功能性残基在介导蛋白质整体的协同性方面起主要作用。
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4347-52. doi: 10.1073/pnas.0607132104. Epub 2007 Mar 5.
10
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.沉默的氢键可通过突变被激活,用于骨形态发生蛋白-2(BMP-2)与激活素IIB型受体的高亲和力相互作用。
BMC Struct Biol. 2007 Feb 12;7:6. doi: 10.1186/1472-6807-7-6.

配体-受体识别中骨形态发生蛋白受体-II 的主体-客体关系定义了特异性。

A host-guest relationship in bone morphogenetic protein receptor-II defines specificity in ligand-receptor recognition.

机构信息

Department of Biochemistry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

出版信息

Biochemistry. 2012 Sep 4;51(35):6968-80. doi: 10.1021/bi3003023. Epub 2012 Aug 23.

DOI:10.1021/bi3003023
PMID:22894880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3481545/
Abstract

One of the most intriguing questions confronting the bone morphogenetic protein family is the mechanism of ligand recognition, because there are more ligands than receptors. Crystal structures of two type II receptors, ActR-II and BMPR-II, are essentially identical, and a loop structure (A-loop) has been suggested to play a role in determining ligand specificity. A solution biophysical study showed mutations of several A-loop residues in these two receptors exert different ligand binding effects. Thus, the issues of mechanism of ligand recognition and specificity remain unresolved. We examined effects of mutations of residues Y40, G47, and S107 in BMPR-II. These residues are not identified as being in contact with the ligand in the BMP-7-BMPR-II complex but are found mutated in genetic diseases. They are likely to be useful in identifying their roles in differentiating the various BMP ligands. Spectroscopic probing revealed little mutation-induced structural change in BMPR-II. Ligand binding studies revealed that Y40 plays a significant role in differentiating three distinct ligands; G47 and S107 affect ligand binding to a lesser extent. The role of the A-loop in ActR-II or BMPR-II is dependent on the host sequence of the receptor extracellular domain (ECD) in which it is embedded, suggesting a host-guest relationship between the A-loop and the rest of the ECD. Computational analysis demonstrated a long-range connectivity between Y40, G47, and S107 and other locations in BMPR-II. An integration of these results on functional energetics and protein structures clearly demonstrates, for the first time, an intradomain communication network within BMPR-II.

摘要

骨形态发生蛋白家族面临的最有趣的问题之一是配体识别的机制,因为配体比受体多。两种 II 型受体 ActR-II 和 BMPR-II 的晶体结构基本相同,并且已经提出了一个环结构(A 环)在决定配体特异性方面起作用。一项溶液生物物理研究表明,这两种受体中的几个 A 环残基的突变会产生不同的配体结合效应。因此,配体识别和特异性的机制问题仍然没有解决。我们检查了 BMPR-II 中残基 Y40、G47 和 S107 突变的影响。这些残基在 BMP-7-BMPR-II 复合物中未被确定为与配体接触,但在遗传疾病中发现发生了突变。它们可能有助于确定它们在区分各种 BMP 配体中的作用。光谱探测显示 BMPR-II 的突变引起的结构变化很小。配体结合研究表明,Y40 在区分三种不同的配体方面起着重要作用;G47 和 S107 对配体结合的影响较小。A 环在 ActR-II 或 BMPR-II 中的作用取决于其嵌入的受体细胞外结构域(ECD)的宿主序列,这表明 A 环与 ECD 的其余部分之间存在主客体关系。计算分析表明,Y40、G47 和 S107 与 BMPR-II 中的其他位置之间存在长程连通性。这些结果在功能能量学和蛋白质结构上的综合,首次清楚地表明了 BMPR-II 内的一个域内通讯网络。